Inventaire - prietenii tai și comunicațiile sunt cea mai buna librărie - Inventaire

Non-anticoagulant heparins and inhibition of cancer

publicat în: Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

Data de publicare: 2008-01-01

Subiectul principal: anticoagulation, anticoagulant

Citează articole 47

Dată

Title

Autori

2007-11-20

Syndecan-1: a dynamic regulator of the myeloma microenvironment
2007-01-01

Heparanase, heparin and the coagulation system in cancer progression

Benjamin Brenner
2007-10-01

The role of tissue factor pathway inhibitor in tumor growth and metastasis
2007-08-28

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo

Graeme O'Boyle, John A Kirby
2007-07-01

Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis

Lubor Borsig
2007

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Israel Vlodavsky
2007-05-29

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Bart Barlogie, Shmuel Yaccoby
2007-04

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
2007-03-05

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Dirk Hose, Hartmut Goldschmidt, Michel Jourdan
2007-01-01

Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects

Lubor Borsig
2007-06-08

P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins

Lubor Borsig
2007-03-08

Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis
2006-07-06

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
2006

The impact of heparanese and heparin on cancer metastasis and angiogenesis

Israel Vlodavsky, Ram Sasisekharan
2006-02-01

Low-molecular-weight heparins and angiogenesis
2006-03-01

Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin
2006-03-01

If heparanase is the answer, what is the question?
2005-10-01

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity
2005-12-01

Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies

Thomas Kelly
2005-04-01

Structural basis for fibroblast growth factor receptor activation

Shaun K Olsen, Moosa Mohammadi
2005-11-01

Heparin octasaccharides inhibit angiogenesis in vivo

Steven D Shnyder, Gordon C. Jayson, Marco Presta
2005-07-01

Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth
2005-02-01

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models.
2005-01-12

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting
2005-01-01

Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

Therese Standal, Magne Børset
2005-08-01

Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival

Janet A Dunn
2004-02-01

Selectins facilitate carcinoma metastasis and heparin can prevent them

Lubor Borsig
2004-01-05

Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library
2004-04-01

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis

Ralf J. Ludwig, Jens Gille
2004-10-20

Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.

Domenico Ribatti, Marco Rusnati, Mirella Belleri, Benito Casu, Annamaria Naggi, Giangiacomo Torri, Claudio Pisano
2004-02-01

Undersulfated and glycol-split heparins endowed with antiangiogenic activity.

Marco Guerrini, Marco Rusnati, Marco Presta, Domenico Ribatti, Mirella Belleri, Benito Casu, Annamaria Naggi, Giangiacomo Torri, Paolo Carminati, Sergio Penco, Claudio Pisano
2004-10-07

Heparanase promotes the spontaneous metastasis of myeloma cells to bone

Larry J Suva, Thomas Kelly

Articol - wd:Q37379726

Bun Venit la Inventaire!

the library of your friends and communities

Ești offline